Advertisement
Advertisement
BNTC
Benitec Biopharma Inc. Common Stock
12.43
USDSponsored
+0.02
+0.16%
Feb 05, 10:07 UTC -5
Open
BNTC Earnings Reports
Positive Surprise Ratio
BNTC beat 8 of 19 last estimates.
42%
Next Report
Next Week
Date of Next Report
Feb 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.22
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/-33.33%
Benitec Biopharma Inc. Common Stock earnings per share and revenue
On Nov 14, 2025, BNTC reported earnings of -0.22 USD per share (EPS) for Q1 26, beating the estimate of -0.37 USD, resulting in a 41.44% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.81% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 8 analysts forecast an EPS of -0.22 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Bristol-Myers Squibb Co.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.12
Actual
$1.26
Surprise
+11.88%
GSK plc - ADR
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.23
Actual
$0.49
Surprise
+111.36%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.82
Actual
$11.44
Surprise
+5.65%
QIAGEN N.V.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.64
Actual
$0.62
Surprise
-3.32%
Bio-Techne Corp.
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.44
Actual
$0.46
Surprise
+3.95%
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
Mesoblast Limited - ADR
Report Date
Jan 29, 2026 For Q1 26
Estimate
-$0.06
Actual
-$0.07
Surprise
-5.90%
AYTU BioPharma, Inc. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
-$0.61
Actual
-$1.05
Surprise
-71.57%
FAQ
What were Benitec Biopharma Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Benitec Biopharma Inc. Common Stock reported EPS of -$0.22, beating estimates by 41.44%, and revenue of $0.00, 0% as expectations.
How did the market react to Benitec Biopharma Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 2.81%, changed from $13.16 before the earnings release to $13.53 the day after.
When is Benitec Biopharma Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 12, 2026.
What are the forecasts for Benitec Biopharma Inc. Common Stock's next earnings report?
Based on 8
analysts, Benitec Biopharma Inc. Common Stock is expected to report EPS of -$0.22 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement